Ectopic Pregnancy
Ectopic pregnancy occurs when a fertilised ovum implants outside the uterine cavity, most commonly in the fallopian tube, and is a potentially life-threatening gynaecological emergency.
Key Facts
Ectopic pregnancy complicates approximately 1 in 80-90 pregnancies (11 per 1,000) in the UK 97% occur in the fallopian tube (ampulla most common site at 70%) Remains a significant cause of first-trimester maternal death in the UK Classic triad: amenorrhoea, abdominal pain, vaginal bleeding (present in only ~50%) Serum βhCG >1,500 IU/L with no intrauterine pregnancy on TVS is highly suspicious NICE NG126 recommends TVS as first-line investigation for women with pain/bleeding in early pregnancy Methotrexate 50mg/m² IM single dose is used for medically managed ectopic (if βhCG <5,000, no cardiac activity, <35mm mass) Risk factors include previous ectopic (10-15% recurrence), PID, tubal surgery, IVF, IUCD in situ
Overview
Key Facts
Ectopic pregnancy is the implantation of a fertilised ovum outside the endometrial cavity. It is a common and potentially life-threatening condition requiring prompt diagnosis and management. Early recognition is essential to prevent tubal rupture and haemodynamic compromise.
Epidemiology
- Incidence: approximately 11 per 1,000 pregnancies in the UK
- Accounts for 0.5% of maternal deaths in the UK
- Peak incidence at age 25-34 years
- Incidence rising due to increased prevalence of risk factors and earlier detection
Aetiology
- Tubal factors: previous PID/salpingitis (especially Chlamydia trachomatis), previous tubal surgery, previous ectopic pregnancy (10-15% recurrence), tubal endometriosis
- Contraceptive factors: progesterone-only pill, IUCD/IUS in situ (does not increase absolute risk but proportion of ectopics increases), previous sterilisation failure
- Assisted reproduction: IVF/ICSI (2-5% ectopic rate)
- Other: smoking (dose-dependent, 2× risk), age >35 years, history of infertility
Pathophysiology
- 97% are tubal: ampullary (70%), isthmic (12%), fimbrial (11%), interstitial/cornual (2-4%)
- Non-tubal sites: ovarian (3%), cervical (<1%), caesarean scar, abdominal/peritoneal (rare)
- Damaged tubal epithelium (from PID, surgery) impairs ovum transport
- Growing ectopic erodes into tubal wall and blood vessels
- Tubal rupture causes intraperitoneal haemorrhage and haemodynamic compromise
Clinical Presentation
Typical Presentation
- Amenorrhoea (6-8 weeks, though may have irregular bleeding mistaken for a period)
- Unilateral lower abdominal/pelvic pain
- Vaginal bleeding (usually scanty, dark brown, 'prune juice')
- Pain may be intermittent or constant
Ruptured Ectopic
- Sudden severe abdominal pain
- Shoulder tip pain (diaphragmatic irritation from haemoperitoneum)
- Haemodynamic compromise: tachycardia, hypotension, syncope
- Peritonism: guarding, rebound tenderness
- Cervical excitation on bimanual examination
Red Flags
- Haemodynamic instability (tachycardia, hypotension)
- Shoulder tip pain
- Syncope or collapse
- Peritonism
- Positive pregnancy test with acute abdomen
Differential Diagnosis
| Diagnosis | Key Features | Investigation |
|---|---|---|
| Miscarriage (threatened/incomplete) | Crampy central pain, heavier bleeding, open os | TVS, serial βhCG |
| Ovarian cyst accident (rupture/torsion) | Sudden unilateral pain, may be haemodynamically unstable | Pelvic USS, pregnancy test |
| Corpus luteum cyst | Unilateral pain in early pregnancy, may rupture | TVS |
| Appendicitis | RIF pain, anorexia, fever, raised WCC | USS, CT if needed |
| Urinary tract infection/renal colic | Dysuria, haematuria, loin-to-groin pain | Urinalysis, USS KUB |
| Pelvic inflammatory disease | Bilateral pain, vaginal discharge, fever | HVS, blood cultures |
Diagnosis / Investigation
Bedside
- Urine pregnancy test (highly sensitive, positive in >99%)
- Observations: HR, BP, temperature
- Urinalysis
Bloods
- Serum βhCG: essential for management decisions; level >1,500 IU/L (discriminatory zone) without intrauterine pregnancy on TVS is highly suspicious
- Serial βhCG at 48 hours: in normal IUP, rises by ≥63%; in ectopic, often rises <63% or plateaus/falls
- FBC (haemoglobin for haemorrhage assessment)
- Group and save / crossmatch if haemodynamically unstable
- Serum progesterone: <20 nmol/L suggests non-viable pregnancy (limited utility)
Imaging
- Transvaginal ultrasound (TVS): first-line investigation (NICE NG126)
- Intrauterine pregnancy visible from βhCG ~1,000-1,500 IU/L
- Ectopic findings: adnexal mass, 'blob sign', 'bagel sign', tubal ring, free fluid in POD
- Empty uterus with positive pregnancy test = pregnancy of unknown location (PUL)
Special Tests
- Diagnostic laparoscopy: definitive if diagnosis uncertain and patient symptomatic
Management
Non-pharmacological
- Expectant management: suitable if βhCG <1,500 IU/L and declining, asymptomatic, able to return for follow-up
- Patient information: ectopic pregnancy warning symptoms, when to attend A&E
- Psychological support: early pregnancy loss counselling
Pharmacological
- Methotrexate 50mg/m² IM single dose:
- Criteria: confirmed ectopic, βhCG <5,000 IU/L (some centres <3,000), no significant pain, adnexal mass <35mm, no fetal cardiac activity, no intrauterine pregnancy
- Monitor βhCG on days 4 and 7: need ≥15% drop between days 4-7
- If insufficient decline, consider second dose or surgery
- Advise reliable contraception for 3 months after methotrexate (teratogenic)
- Anti-D immunoglobulin for RhD-negative women if surgical management
Surgical/Interventional
- Laparoscopic salpingectomy: first-line surgical treatment (preferred if contralateral tube is healthy)
- Laparoscopic salpingotomy: considered if contralateral tube is damaged/absent (fertility-sparing); requires serial βhCG follow-up for persistent trophoblast
- Emergency laparotomy: for ruptured ectopic with haemodynamic instability
Referral Criteria
- All suspected ectopic pregnancies require urgent assessment in an early pregnancy assessment unit (EPAU)
- Emergency surgical referral if haemodynamically unstable
- Follow-up with serial βhCG until <5 IU/L (expectant or medical management)
Prognosis
- Maternal mortality: 0.2 per 1,000 ectopic pregnancies in the UK (significantly improved with early detection)
- Success rate of methotrexate (single dose): 65-95% (higher with lower initial βhCG)
- Subsequent intrauterine pregnancy rate: 60-70% after salpingectomy, 70-80% after salpingotomy
- Recurrence risk: 10-15% after one ectopic; 25% after two
- Persistent trophoblast after salpingotomy: 5-20% (requires serial βhCG monitoring)
Other Relevant Information
Management Pathway Summary
| Parameter | Expectant | Medical (MTX) | Surgical |
|---|---|---|---|
| βhCG | <1,500 and declining | <5,000 | Any level |
| Symptoms | Minimal | Minimal pain | Any symptoms |
| Mass size | <35mm | <35mm | Any size |
| Cardiac activity | No | No | Yes or No |
| Follow-up | Serial βhCG | Day 4 and 7 βhCG | Histology + βhCG |
βhCG Interpretation in Early Pregnancy
| Pattern | Likely Diagnosis |
|---|---|
| Doubling every 48h (≥63% rise) | Viable IUP |
| Rising <63% in 48h | Ectopic pregnancy |
| Declining >50% in 48h | Miscarriage |
| Plateau or slow decline | Ectopic or retained products |